维普中文期刊产品整合服务
19篇 您的检索式:作者名="Cleary JF"
    题名 作者 年代 出处 被引量
1Cancer pain management显示文摘Cleary JF 2000Cancer Control2000,7,:1
2The pharmacologic management of cancer pain显示文摘Cleary JF 2007J Palliat Med2007,10,6:1
3Phase Ⅰ clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol显示文摘Thomas JP Tutsch KD Cleary JF 2002Cancer Chemother Pharmacol2002,50,12:1
4The pharmacologic management of cancer pain 显示文摘Cleary JF 2007J Palliat Med2007,10,6:1
5Phase I clinical and pharmacoki- netic trial of the cyclin-dependent kiuase inhibitor flavopiridol显示文摘Thomas JP Tutsch KD Cleary JF 2002Can- cer Chemother Pharmacol2002,50,6:1
6Progression of carotid ar- tery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study 显示文摘Polak JF Backlund JY Cleary PA 2011Diabetes2011,60,2:1
7Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults显示文摘O'cleary DH Polak JF Kronmal RA 1999N Engl J Med1999,340,1:1
8Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol显示文摘Thomas JP Tutsch KD Cleary JF 2002Cancer Chemother Pharmacol2002,50,:1
9Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study显示文摘Polak JF Backlund JY Cleary PA 2011Diabetes2011,60,2:1
10Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol 显示文摘Thomas JP Tutsch KD Cleary JF 2007Cancer Chemother Pharmacol2007,50,6:1
11Progression of carotid artery intima-media thickness during 12years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications(DCCT/EDIC)study显示文摘Polak JF Backlund JY Cleary PA 2011Diabetes2011,60,2:1
12Progression of carotid artery inti- ma-media thickness during 12 years in the Diabetes Control and Compli- cations Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study显示文摘Polak JF Backlund JY Cleary PA 2011Diabetes2011,60,2:1
13Phase I clinical and pharmacokinetie trial of the cyclin- dependent kinase inhibitor favopirido 1 显示文摘Thomas JP Tutsch KD Cleary JF 2002Cancer Chemother Pharmacol2002,50,6:1
14Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study 显示文摘Polak JF Backlund JY Cleary PA 2011Diabetes2011,60,2:1
15Progression of carotid artery intima-media thickness during 12 years in the Diabetes Con- troI and Complications Trial/Epidemiology of Diabetes Interven- tions and Complications ( DCCT/EDIC ) study 显示文摘Polak JF Backlund JY Cleary PA 2011Diabetes2011,60,2:1
16Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol显示文摘Thomas JP Tutsch KD Cleary JF 2002Cancer Chemotherapy and Pharmacolgy2002,50,6:1
17The pharmacologic management of cancer pain 显示文摘Cleary JF 2007J Palliat Med2007,10,6:1
18The pharmacologic management of cancer pain显示文摘Cleary JF 0,,:1
19Cancer pain management显示文摘Cleary JF 2000Cancer Control2000,7,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费